Currently out of the existing stock ratings of Ben Hendrix, 45 are a HOLD (21.95%), 160 are a BUY (78.05%).

Ben Hendrix

Work Performance Price Targets & Ratings Chart

Analyst Ben Hendrix, currently employed at RBC, carries an average stock price target met ratio of 50.18% that have a potential upside of 25.43% achieved within 153 days.

Ben Hendrix’s has documented 413 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Financial Services, Communication Services sectors.

Most recent stock forecast was given on AMED, Amedisys at 16-Apr-2025.

Wall Street Analyst Ben Hendrix

Analyst best performing recommendations are on SLQT (SELECTQUOTE).
The best stock recommendation documented was for SLQT (SELECTQUOTE) at 2/8/2022. The price target of $3 was fulfilled within 3 days with a profit of $0.44 (12.79%) receiving and performance score of 42.64.

Average potential price target upside

of $73.13 (15.57%) on UNH (UNITEDHEALTH GROUP).
of $65.64 (13.1%) on CHE (CHEMED CORP).
of $46.12 (12.96%) on HUM (HUMANA).

ADUS Addus HomeCare AHCO Adapthealth Corp CHE Chemed Corp CI Cigna Corp EHC Encompass Health Corp ENSG The Ensign Group GOCO GoHealth HCA HCA Holdings HUM Humana MAX MediaAlpha PNTG Pennant Group SEM Select Medical Holdings SGRY Surgery Partners SLQT Selectquote UNH UnitedHealth Group WBA Walgreens Boots Alliance AVAH Aveanna Healthcare Holdings CVS CVS Health Corp EHTH eHealth ELV Elevance Health THC Tenet Healthcare ACHC Acadia Healthcare Company BHG Bright Health Group BKD Brookdale Senior Living CYH Community Health Systems UHS Universal Health Services AMED Amedisys

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Ben Hendrix (RBC)